• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用类固醇抑制药物治疗重度抑郁症。

Treatment of major depression with steroid suppressive drugs.

作者信息

Murphy B E

机构信息

Department of Medicine, McGill University, Montreal, Canada.

出版信息

J Steroid Biochem Mol Biol. 1991 Aug;39(2):239-44. doi: 10.1016/0960-0760(91)90069-h.

DOI:10.1016/0960-0760(91)90069-h
PMID:1888684
Abstract

The hypercorticism frequently observed in major depression, unaccompanied by signs of Cushing's syndrome, is still poorly understood. One suicidal young woman, with very high cortisol levels and unusual resistance to dexamethasone suppression, is described. She was successfully treated with steroid suppressive drugs (aminoglutethimide, metyrapone), had a prompt and complete remission and has remained well for more than two years on no medication. This success prompted an on-going clinical trial of this therapy. The available drugs and a working hypothesis of their action are discussed.

摘要

在重度抑郁症中经常观察到的皮质醇增多症,且无库欣综合征的体征,目前仍了解甚少。本文描述了一名有自杀倾向的年轻女性,其皮质醇水平极高,对地塞米松抑制试验有异常抵抗。她接受类固醇抑制药物(氨鲁米特、美替拉酮)治疗成功,迅速完全缓解,且在未用药的情况下保持良好状态超过两年。这一成功促使正在进行该疗法的临床试验。文中讨论了可用药物及其作用的工作假设。

相似文献

1
Treatment of major depression with steroid suppressive drugs.使用类固醇抑制药物治疗重度抑郁症。
J Steroid Biochem Mol Biol. 1991 Aug;39(2):239-44. doi: 10.1016/0960-0760(91)90069-h.
2
Aminoglutethimide and metyrapone in the management of Cushing's syndrome.氨鲁米特和甲吡酮在库欣综合征治疗中的应用
Acta Endocrinol (Copenh). 1985 Aug;109(4):451-7. doi: 10.1530/acta.0.1090451.
3
Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.库欣综合征的药物控制。氨鲁米特与美替拉酮联合治疗。
Acta Endocrinol (Copenh). 1976 Jun;82(2):330-41.
4
Response to steroid suppression in major depression resistant to antidepressant therapy.
J Clin Psychopharmacol. 1991 Apr;11(2):121-6.
5
[Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
Dtsch Med Wochenschr. 1987 Oct 2;112(40):1532-5. doi: 10.1055/s-2008-1068285.
6
Neuroendocrine responses to inhibitors of steroid biosynthesis in patients with major depression resistant to antidepressant therapy.
Can J Psychiatry. 1998 Apr;43(3):279-86. doi: 10.1177/070674379804300307.
7
[Broncho-pulmonary cancer with true or degraded hypercorticism].[伴有真性或减退性皮质醇增多症的支气管肺癌]
Presse Med (1893). 1969 Nov 29;77(51):1891-4.
8
[Cushing's syndrome. Medical treatment of adrenal hypercorticism].[库欣综合征。肾上腺皮质功能亢进的医学治疗]
Horm Res. 1980;13(4-5):317-24. doi: 10.1159/000179298.
9
[Medical therapy of hyperadrenalism].[肾上腺功能亢进的医学治疗]
Minerva Med. 1973 Mar 14;64(14):682-4.
10
Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.91例库欣综合征患者药物治疗中对甲吡酮的短期和长期反应
Clin Endocrinol (Oxf). 1991 Aug;35(2):169-78. doi: 10.1111/j.1365-2265.1991.tb03517.x.

引用本文的文献

1
Antiglucocorticoids as Treatments for Depression : Rationale for Use and Therapeutic Potential.抗糖皮质激素作为抑郁症的治疗方法:使用原理及治疗潜力
CNS Drugs. 1996 May;5(5):311-20. doi: 10.2165/00023210-199605050-00001.
2
Metyrapone in treatment-resistant depression.米替拉酮治疗抵抗性抑郁症。
Ther Adv Psychopharmacol. 2012 Aug;2(4):139-49. doi: 10.1177/2045125312436597.
3
Hormone treatment of depression.抑郁症的激素治疗
Dialogues Clin Neurosci. 2011;13(1):127-38. doi: 10.31887/DCNS.2011.13.1/rjoffe.
4
Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?糖皮质激素抑制在抑郁症治疗中的应用:我们能否突破内分泌下丘脑的局限来思考?
Depress Anxiety. 2009;26(7):641-9. doi: 10.1002/da.20546.
5
Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators.应激激素在健康与疾病中的中枢效应:理解应激及应激介质的保护和损害作用。
Eur J Pharmacol. 2008 Apr 7;583(2-3):174-85. doi: 10.1016/j.ejphar.2007.11.071. Epub 2008 Jan 30.
6
Innovative approaches for the treatment of depression: targeting the HPA axis.抑郁症治疗的创新方法:针对下丘脑-垂体-肾上腺(HPA)轴
Neurochem Res. 2008 Apr;33(4):691-707. doi: 10.1007/s11064-007-9518-3. Epub 2007 Oct 25.
7
Strain-specific steroidal control of pituitary function.垂体功能的菌株特异性甾体控制。
J Endocrinol. 2007 Mar;192(3):515-25. doi: 10.1677/JOE-06-0145.
8
Protective and damaging effects of stress mediators: central role of the brain.应激介质的保护和损伤作用:大脑的核心作用
Dialogues Clin Neurosci. 2006;8(4):367-81. doi: 10.31887/DCNS.2006.8.4/bmcewen.
9
[New developments in pharmacotherapy of depression].[抑郁症药物治疗的新进展]
Nervenarzt. 2004 Mar;75(3):273-80. doi: 10.1007/s00115-003-1517-2. Epub 2003 May 10.
10
Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486.糖皮质激素受体拮抗剂在重度抑郁症治疗中的可能应用:使用RU 486的初步结果
J Psychiatry Neurosci. 1993 Nov;18(5):209-13.